IRIX CFO Romeo Dizon Purchases Additional Shares

IRIX's Chief Financial Officer, Romeo Dizon, has been active in buying shares of the company. On June 12, 2026, Dizon purchased 975 shares at an average price of $1.14 each, totaling about $1,111.50. This purchase was not part of a pre-scheduled plan.

Insider Buying and Selling at IRIDEX Corporation

Romeo Dizon has been consistently buying shares of IRIX. In addition to his purchase on June 12, he acquired 1,675 shares on June 11 and 2,400 shares on June 8, with prices ranging from $1.12 to $1.17. On June 5, he bought 2,521 shares at $1.15, and on June 3, he purchased 2,400 shares at $1.17. Meanwhile, Patrick Mercer, the President and CEO, sold 19,233 shares at $1.01 on May 26, 2026.

Other Institutional Activity in IRIX

Institutional investors have shown varied interest in IRIX. Vanguard Capital Management LLC increased its holdings significantly by adding 514,593 shares, now holding a total of 514,593 shares valued at approximately $519,739. Renaissance Technologies LLC also expanded its position with an additional 25,067 shares, bringing its total to 396,627 shares worth about $400,593. Geode Capital Management, LLC boosted its holdings by 24,951 shares, ending with 160,159 shares valued at $161,796. Citadel Advisors LLC made a notable increase of 26,456 shares, resulting in a total of 60,851 shares worth $61,460.

Analysts Set New Price Targets

Analysts have maintained varied ratings on IRIX. On March 27, 2024, Stifel Nicolaus reaffirmed its hold rating with a price target of $2.00. Earlier, on March 10, 2023, Roth MKM maintained a buy rating with a higher target of $6.25, indicating optimism about the company's prospects. The consensus among analysts shows a mix of hold and buy ratings, reflecting differing views on IRIX's potential.

Bottom Line

Romeo Dizon's recent stock purchases highlight his confidence in IRIX, while other institutional investors have also adjusted their stakes. These insider activities and institutional moves provide insight into the current sentiment surrounding IRIX. Analyst opinions remain mixed, with some maintaining optimistic targets. As always, remember that insider transactions and 13F filings provide a historical view and may not reflect current positions.